Ideaya Biosciences Inc (IDYA) concluded trading on 01/11/24 at a closing price of $36.93, with 4.68 million shares of worth about $172.79 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 62.40% during that period and on Thursday the price saw a gain of about 0.08%. Currently the company’s common shares owned by public are about 64.46M shares, out of which, 55.54M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 29 times over the past 12 months. They bought 48,571 shares in 12 of the transactions. In 17 selling transactions, insiders dumped 43,470 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ideaya Biosciences Inc (NASDAQ: IDYA) started trading at $36.75, below -$0.15 from concluding price of the previous day. Stock saw a price change of 6.70% in past 5 days and over the past one month there was a price change of 17.24%. Year-to-date (YTD), IDYA shares are showing a performance of 3.79% which increased to 114.46% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $13.29 but also hit the highest price of $36.96 during that period. The average intraday trading volume for Ideaya Biosciences Inc shares is 958.20K. The stock is currently trading 6.11% above its 20-day simple moving average (SMA20), while that difference is up 15.18% for SMA50 and it goes to 45.71% higher than SMA200.
Ideaya Biosciences Inc (NASDAQ: IDYA) currently have 64.46M outstanding shares and institutions hold larger chunk of about 80.95% of that.
The stock has a current market capitalization of $2.38B and its 3Y-monthly beta is at 0.81. It has posted earnings per share of -$1.95 in the same period. It has Quick Ratio of 19.37 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for IDYA, volatility over the week remained 4.54% while standing at 3.75% over the month.
Stock’s fiscal year EPS is expected to drop by -34.28% while it is estimated to decrease by -23.72% in next year.
Analysts at 10 brokerage firms have issued recommendations for the Ideaya Biosciences Inc (IDYA)’s stock and average of those rates the stock at a “Strong Buy” and assign it a score of 1.10. Out of those 10 Wall Street analysts, 9 recommended a “Buy” rating, while 0 were in favor recommending the stock as a “Hold” and 0 analyst recommended the stock as “Sell”.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by SVB Securities on August 08, 2023 offering an Outperform rating for the stock and assigned a target price of $33 to it.
